LSA
TEVA icon

Leonteq Securities AG’s Teva Pharmaceuticals TEVA Stock Holding History

Leonteq Securities AG’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-205,700
Closed -$1.88M – 1324
2022
Q4 		$1.88M Buy
+205,700
New +$1.79M 0.07% 206

Other funds holding TEVA

HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return
FAF
Fjarde Ap-fonden Stockholm, Sweden $20.9B AUM 36.93% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Leonteq Securities AG's TEVA Position: Q2 2026 in Review

Leonteq Securities AG reduced its Teva Pharmaceuticals (TEVA) stake by 83% in Q2 2026, selling an estimated $169K and leaving 1,063 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #866.

Leonteq Securities AG first reported a position in TEVA in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.34M in Q3 2023. 208 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Leonteq Securities AG held 1,063 shares of Teva Pharmaceuticals worth $36K as of Q2 2026.
  • Leonteq Securities AG sold 5,084 Teva Pharmaceuticals shares in Q2 2026, an estimated $169K.
  • Teva Pharmaceuticals made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #866 holding.
  • Leonteq Securities AG first reported a position in Teva Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • Leonteq Securities AG's Teva Pharmaceuticals position peaked at $3.34M in Q3 2023.
  • 208 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.